Medical/Pharmaceuticals

Organon accelerates Women's Health progress across Asia Pacific with 2026 Her Health Grants

SYDNEY, March 30, 2026 /PRNewswire/ -- Organon Asia Pacific Cluster today announced the 2026 Her Health Grant recipients for the Asia Pacific region, marking a significant milestone in efforts to strengthen and expand women's health initiatives across the region. The Her Health Grants are design...

2026-03-30 06:31 5060

Foshan Launches First Provincial-Level International Medical Pilot

Foshan Fosun Chancheng Hospital Sets New Benchmark for Greater Bay Area Healthcare FOSHAN, China, March 29, 2026 /PRNewswire/ -- On March 28, Foshan Fosun Chancheng Hospital inaugurated the International Medical Center (FIMC), Foshan's first provincial-level international medical pilot, supporti...

2026-03-29 14:54 4918

Better by MTA Expands Its Global Elite Network with Distinguished New Platinum Members

PALM BEACH GARDENS, Fla., March 27, 2026 /PRNewswire/ -- Better by MTA, the premier global platform connecting medical travelers with trusted facilitators and accredited healthcare providers, proudly announces the addition of distinguished new Platinum Members. These leaders in international hosp...

2026-03-27 22:40 5628

Akeso Reports Full-Year 2025 Financial Results

HONG KONG, March 26, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2025 annual results, highlighting a year of comprehensive, strategic leaps across all facets of its business. Commercial Operations Enter a New Phase of Growth In 2025, Akeso achieved record ...

2026-03-27 11:54 8618

Zimmer Biomet Wins Three Awards at Healthcare Asia Medtech Awards 2026

Awards Recognize Innovations in Infection Measures, AI-Driven Recovery and Surgeon Engagement across Asia Pacific. SINGAPORE, March 27, 2026 /PRNewswire/ -- Zimmer Biomet (NYSE and SIX: ZBH), a global medical technology leader, today announced it received three awards at the Healthcare Asia Medt...

2026-03-27 08:30 5729

Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million

CAMBRIDGE, Mass., March 26, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Tenacia Biotechnology (Hong Kong) Co., Limited ("Tenacia"), a commercial-stage biopharmaceutical company dedicated t...

2026-03-26 22:08 6726

CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0

Rapid Advancement Across Core R&D Pipeline * The global, multicenter Phase I/II clinical trial of CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) is actively enrolling patients in Australia and China, and the Phase II IND application has been approved in the US. CS2009 demonstrates an excellent...

2026-03-26 21:32 12542

HealYou Built a Mental Health Platform for the Millions of Asians Who Would Never Use One

Asia is rewriting mental health — and the West may not be ready for what comes next TAIPEI and NEW YORK, March 26, 2026 /PRNewswire/ -- In America, Chinese Communities Are Quietly Rewriting the Rules of Mental Health Chinese Online Therapist...

2026-03-26 21:00 4527

Neurophet Signs MOU with ALZ-NET to Facilitate Imaging Monitoring Infrastructure for Alzheimer's Disease Therapies

* Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Neurophet's key solutions * Collaboration expected to leverage Neurophet AQUA, Neurophet SCALE PET and Neurophet AQUA AD Plus SEOUL, South Korea, March 26, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Ja...

2026-03-26 21:00 9564

CStone Updated Clinical Progress and Key Phase I/II Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)

Key Highlights: * Excellent Safety Profile:  As of mid-March 2026, 113 heavily pretreated patients with solid tumors have been enrolled in the Phase I trial of CS2009, with a median follow-up of approximately 6 months. The more mature data continue to show a favorable safety profile, with23% i...

2026-03-26 20:53 8148

C-Ray Therapeutics and SHINE Technologies Enter Strategic Partnership for Exclusive Distribution of No-Carrier-Added Lu-177 in Mainland China

CHENGDU, China and JANESVILLE, Wis., March 26, 2026 /PRNewswire/ -- C-Ray Therapeutics (Chengdu, China), a global radiopharmaceutical CRDMO, today announced the execution of aMaster Radioisotope Supply Agreement with SHINE Technologies, LLC (Janesville, Wisconsin, USA), establishing a long-term, ...

2026-03-26 20:53 5191

Getinge publishes Annual Report for 2025

GOTHENBURG, Sweden, March 26, 2026 /PRNewswire/ -- Today, Getinge publishes its Annual Report for 2025, including the Sustainability statement. The year was marked by geopolitical friction and significant cost impacts from tariffs and currency movements, while the company delivered strong underly...

2026-03-26 20:12 4539

Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards

* Reinforcing long-term commitment to embedding sustainability across operations and partnerships * Continuing to support clients in delivering high-quality, life-saving medicines to patients worldwide INCHEON, South Korea, March 26, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a ...

2026-03-26 20:00 6246

Peijia Medical Announces 2025 Annual Results

SUZHOU, China, March 26, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced its annual results for the year ended December 31, 2025 on March 25, 2026. During th...

2026-03-26 20:00 6480

Chula, Thai Red Cross Society Partner to Bring "SALYWA" Artificial Saliva to Patients

BANGKOK, March 26, 2026 /PRNewswire/ -- Chulalongkorn University , in collaboration with the Thai Red Cross Society  and Specialty Innovation Co., Ltd., held a press conference announcing the licensing agreement for research utilization a...

2026-03-26 18:04 5129

Innovent Announces 2025 Annual Results and Business Updates

From China Leadership to Global Premier: Revenue Surpasses RMB 10 Billion, Entering the Era of Profitability and Globalization SAN FRANCISCO and SUZHOU, China, March 26, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develop...

2026-03-26 18:00 8603

Lasermach by Wingderm® Receives FDA Clearance for All Three Wavelengths

BEIJING, March 26, 2026 /PRNewswire/ -- Wingderm®, a manufacturer of medical aesthetic devices, announces that its Lasermach system has received expanded clearance from the U.S. Food and Drug Administration (FDA). With this latest clearance, Lasermach now achieves FDA clearance across all three w...

2026-03-26 18:00 3394

HEALTH SUMMIT ASIA 2026 CONFIRMS OVER 30 GLOBAL HEALTHCARE LEADERS FOR CONFERENCE

KUALA LUMPUR, Malaysia, March 26, 2026 /PRNewswire/ -- Health Summit Asia (HSA) 2026 has confirmed more than 30 distinguished speakers from across the globe, underscoring the event's scale and significance for Malaysia and the wider region. Their calibre spans public health, cancer research, AI i...

2026-03-26 14:30 4868

GC Biopharma Receives Marketing Authorization for Varicella Vaccine 'BARYCELA Inj.' in Guatemala

- First regulatory clearance in Latin America marks a strategic milestone for regional market expansion - World's first antibiotic-free manufacturing process ensures superior safety profile YONGIN, South Korea, March 26, 2026 /PRNewswire/ -- GC Biopharma(006280.KS), a leading provider of biophar...

2026-03-26 14:23 4322

Alphamab Oncology Reports Full Year 2025 Financial Results and Business Highlights

SUZHOU, China, March 26, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2025 and highlighted recent business progress. Key Highlights * KN026 (Anbenitamab) achieved robust PFS and OS benefits in second- or third-lin...

2026-03-26 13:13 7625
1 ... 47484950515253 ... 646

Week's Top Stories